These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 33894267)
1. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway. Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267 [TBL] [Abstract][Full Text] [Related]
2. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738 [TBL] [Abstract][Full Text] [Related]
3. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis. Zhang R; Lian Y; Xie K; Cai Y; Pan Y; Zhu Y Bioengineered; 2021 Dec; 12(2):9162-9173. PubMed ID: 34696683 [TBL] [Abstract][Full Text] [Related]
4. [Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway]. Geng Z; Yang J; Niu M; Liu X; Shi J; Liu Y; Yao X; Zhang Y; Zhang X; Hu J Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug; 44(8):1476-1484. PubMed ID: 39276043 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway. Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170 [TBL] [Abstract][Full Text] [Related]
6. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway. Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339 [TBL] [Abstract][Full Text] [Related]
7. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer. Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441 [TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766 [TBL] [Abstract][Full Text] [Related]
9. Fat mass and obesity-associated protein (FTO)-induced upregulation of flotillin-2 (FLOT2) contributes to cancer aggressiveness in diffuse large B-cell lymphoma (DLBCL) via activating the PI3K/Akt/mTOR signal pathway. Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A Arch Biochem Biophys; 2024 Aug; 758():110072. PubMed ID: 38914215 [TBL] [Abstract][Full Text] [Related]
10. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer. Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129 [TBL] [Abstract][Full Text] [Related]
11. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway. Wang RY; Chen XW; Zhang WW; Jiang F; Liu MQ; Shen XB Mol Med Rep; 2020 Feb; 21(2):842-850. PubMed ID: 31974627 [TBL] [Abstract][Full Text] [Related]
12. ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway. Yu W; Zhang Q; Ali M; Chen B; Sun Q; Wang D Dig Dis Sci; 2024 Oct; 69(10):3786-3798. PubMed ID: 39322809 [TBL] [Abstract][Full Text] [Related]
13. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway. Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425 [TBL] [Abstract][Full Text] [Related]
14. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635 [TBL] [Abstract][Full Text] [Related]
15. Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy. Zhu Y; Yang J; Li Y; Xu J; Fang Z Med Oncol; 2023 Mar; 40(5):130. PubMed ID: 36971873 [TBL] [Abstract][Full Text] [Related]
16. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway. Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
18. CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway. Gao LZ; Wang JQ; Chen JL; Zhang XL; Zhang MM; Wang SL; Zhao C Appl Biochem Biotechnol; 2023 Nov; 195(11):6913-6926. PubMed ID: 36951936 [TBL] [Abstract][Full Text] [Related]
19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
20. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]